Angewandte Chemie (International ed. in English) · 2026
Zinc-Complex Orchestrating Pyroptosis for Hypoxia-Tolerant Photoimmunotherapy.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
An Jinyu, Song Jia-Xing, Zhou Ling-Xiao, Pan Xiu, Liu Kun-Mei, Wan Yu, Jiang Yan, Yu Xiao-Qi, Feng Shun, Wu Ming-Yu
Аннотация
Photon-driven pyroptosis represents an advanced and promising modality in anti-tumor immunotherapy, offering new avenue in combating cancer recurrence and metastasis. Essential metal-complex shows great potential in photoimmunotherapy, which however hardly generates reactive oxygen species (ROS) to active photoimmunotherapy under light irradiation due to low spin-orbit coupling (SOC) resulting in intersystem crossing (ISC) being blocked. To address this challenge, we innovatively proposed the concept of essential-metal ion as an electron-withdrawing group to modulate the donor-acceptor (D-A) system, thereby significantly improving ROS generation efficiency. As a proof of concept, we designed and synthesized a series of Zn2+-complexes through constructing enhanced D-A systems. Zn2+ coordination efficiently enhances the ISC by lowering the excited singlet-triplet energy gap (ΔES1-T1), leading to exceptionally high ROS generation efficiency through Type I mechanisms to overcome hypoxia and the immunosuppression of tumor microenvironment. In these Zn2+-complexes, Zn-TPY-TPA-DTZ can photodynamically damage lysosomes to trigger pyroptosis, which further induce anti-tumor immune responses through the promotion of immunogenic cell death (ICD), and ultimately generates a robust anti-tumor immune response and curbed the proliferation of 4T1 tumors in vivo. This study provides systematic guidance for the rational design of advanced Zn2+-complexes, propelling advancements in cancer treatment strategies.